Penn Vet to study hemp-based canine supplementMay 28, 2019A trial at the University of Pennsylvania School of Veterinary Medicine (Penn Vet) will be looking at the effectiveness of a hemp-based supplement to relieve symptoms of canine joint immobility. Approximately 60 dogs who are suffering from inflammation secondary to osteoarthritis will be split into three groups. One group will receive Mobility, which was developed by Dixie Brands' subsidiary Therabis. The second group will receive CBD, and the last group will receive a placebo. The dogs will then be studied to see which group achieves a better outcome. "We are honored to have a Therabis product selected by the world-renowned experts at Penn Vet for their first major study of the effects of natural hemp oil to reduce joint pain in dogs," says Therabis cofounder, Stephen M. Katz, DVM. "Our experience in my clinic has shown cannabidiol (CBD) is an effective treatment in reducing inflammatory response. We have a passion for improving dogs' quality of life, and we look forward to learning all we can about therapeutic methods to achieve this." Physical tests will be used to measure the effectiveness of the products, mostly focusing on the front leg joints. Results are expected in approximately 12 months.
SPONSORED CONTENTA brighter future for parvovirus patientsOur Canine Parvovirus Monoclonal Antibody helps puppies recover faster, and current users report reductions in clinic stress during parvo treatment.1,2 Find out why veterinary teams are embracing CPMA. + Read More
Kansas State University to study impact of supplement in geriatric dogsMarch 8, 2019Kansas State University College of Veterinary Medicine is set to study the impact of a lean muscle supplement in geriatric dogs. Forty dogs suffering from three of the four following conditions will be enrolled in the study: • weakness; • weight loss; • slowed or altered mobility; and • exercise intolerance. The study—which will test MYOS RENS Technology's Fortetropin—will be performed under the supervision of Kenneth R. Harkin, DVM, DACVIM (SAIM), professor and section head of small animal internal medicine. All the dogs will be fitted with an activity collar. After monitoring their activity for two weeks, 20 dogs will be assigned to receive the supplement and 20 will receive a placebo. Activity levels will continue to be monitored and the quality of life assessment, based on the Liverpool Osteoarthritis in Dogs questionnaire, will be used to evaluate results. "Pet owners often remark their dog is slowing down as they enter their golden years," Dr. Harkin says. "Although osteoarthritis is often tipped as the culprit, the loss of muscle mass associated with old age is an underappreciated cause. Geriatric dogs with muscle mass loss fatigue easily, which by itself can negatively impact their quality of …
All-natural pet supplement to expand reach following distribution agreementNovember 19, 2018More than 6,000 veterinary hospitals can now purchase MYOS Canine Muscle Formula thanks to a recent distribution agreement between MYOS RENS Technology Inc., and Miller Veterinary Supply East.
